|
Option 1: Live
|
Option 2: Self-Study
|
Both of these options are available to you when you register. Remember, you may only participate in one of the two options, and credit for each session may only be received one time.
Day 1: Thursday, April 15
Time (Pacific/Eastern) | Discussion | |
7:00 – 7:30 AM (PT) 10:00 – 10:30 AM (ET) |
Welcome and Introduction | |
7:30 – 8:30 AM (PT) 10:30 – 11:30 AM (ET) |
Sol Silverman Memorial Lecture |
|
8:30 – 9:00 AM (PT) 11:30 – 12:00 PM (ET) |
Break | |
Plenary Session 1: The Pursuit of Better Patient-Centered Outcomes |
||
9:00 – 9:35 AM (PT) 12:00 – 12:35 PM (ET) |
Plenary Session 1A | Oral Cancer awareness: Support, Advocacy, and Hope for Better Outcomes | |
9:35 – 10:10 AM (PT) 12:35 – 1:10 PM (ET) |
Plenary Session 1B | Standardization and Validation of Treatment Outcome Measures in Oral Mucosal Lesions | |
10:10 – 10:45 AM (PT) 1:10 – 1:45 PM (ET) |
Plenary Session 1C | Disease Definition and Diagnostic Criteria in Neuropathic Pain: A Call for Consensus |
|
10:45 – 11:00 AM (PT) 1:45 – 2:00 PM (ET) |
Plenary Session 1 Live Q&A with Speakers | |
11:00 – 12:00 PM (PT) 2:00 – 3:00 PM (ET) |
Long Break |
|
Oral Medicine Practice Session | ||
12:00 – 12:35 PM (PT) 3:00 – 3:35 PM (ET) |
OMP Session Lecture 1 | Infective Endocarditis Prevention: An Oral Medicine Researcher’s Perspective |
|
12:35 – 1:10 PM (PT) 3:35 – 4:10 PM (ET) |
OMP Session Lecture 2 | Oral Health and Dental Procedures Infectious Cardiovascular Conditions: The Risk of Infection from the Cardiologist’s Perspective | |
1:10 – 1:45 PM (PT) 4:10 – 4:45 PM (ET) |
OMP Session Lecture 3 | Oral Health and Infectious Cardiovascular Conditions: Does the Risk of Dental Therapy Outweigh the Benefit in Patients with Compromised Cardiovascular Health? |
|
1:45 – 2:00 PM (PT) 4:45 – 5:00 PM (ET) |
OMP Session Live Q&A | |
2:00 – 2:45 PM (PT) 5:00 – 5:45 PM (ET) |
General Assembly Meeting | |
2:00 – 5:00 PM (PT) 5:00 – 8:00 PM (ET) |
Oral Abstracts 2020 | Self Study Session |
Time (Pacific/Eastern) | Discussion | |
Plenary Session 2: Neoplasia: Extending the Frontiers of Knowledge |
||
7:00 – 7:35 AM (PT) 10:00 – 10:35 AM (ET) |
Plenary Session 2A | Chimeric Antigen Receptor (CAR) T-cell Therapy: The Current Success and the Future Promises in Combating Hematologic Neoplasia | |
7:35 – 8:10 AM (PT) 10:35 – 11:10 AM (ET) |
Plenary Session 2B | Beyond the Phenotypic Characteristics of Dysplasia: Insights into the Future |
|
8:10 – 8:45 AM (PT) 11:10 – 11:45 AM (ET) |
Plenary Session 2C | Oral Neoplasia in People Living with HIV: Divide, Detect and Conquer | |
8:45 – 9:00 AM (PT) 11:45 – 12:00 PM (ET) |
Plenary Session 2 Live Q&A | |
9:00 – 9:30 AM 12:00 – 12:30 PM |
Break |
|
9:30 – 11:00 AM (PT) 12:30 – 2:00 PM (ET) |
Clinicopathologic Expert Panel |
|
11:00 – 12:00 PM (PT) 2:00 – 3:00 PM (ET) |
Long Break | |
12:00 – 1:30 PM (PT) 3:00 – 4:30 PM (ET) |
Lester Burket Awards Lecture | |
1:30 – 2:30 PM (PT) 4:30 – 5:30 PM (ET) |
The World Workshop on Oral Medicine |
|
2:30 – 5:30 PM (PT) 5:30 – 8:30 PM (ET) |
Oral Abstracts 2021 | Self Study Session |
Time (Pacific/Eastern) | Discussion | |
7:00 – 7:45 AM (PT) 10:00 – 10:45 AM (ET) |
Jonathan Ship Lecture | The Impact of Head and Neck Cancer Radiotherapy on Salivary Flow and its Subsequent Recovery: Results of the OraRad study |
|
7:45 – 8:30 AM (PT) 10:45 – 11:30 AM (ET) |
Samuel Charles Miller Lecture |
|
8:30 – 9:00 AM (PT) 11:30 – 12:00 PM (ET) |
Break |
|
Plenary Session 3 | A Global Perspective of Oral Medicine: History, Current Status, and International Collaborative Efforts (A Virtual Discussion Panel) | ||
9:00 – 9:10 AM (PT) 12:00 – 12:10 PM (ET) |
Plenary 3 Global Perspective | Saudi Arabia | |
9:10 – 9:20 AM (PT) 12:10 – 12:20 PM (ET) |
Plenary 3 Global Perspective | Nigeria |
|
9:20 – 9:30 AM (PT) 12:20 – 12:30 PM (ET) |
Plenary 3 Global Perspective | Sweden | |
9:30 – 9:40 AM (PT) 12:30 – 12:40 PM (ET) |
Plenary 3 Global Perspective | China | |
9:40 – 9:50 AM (PT) 12:40 – 12:50 PM (ET) |
Plenary 3 Global Perspective | Brazil | |
9:50 – 11:00 AM (PT) 12:50 – 2:00 PM (ET) |
Plenary Session 3 Live Q&A | |
11:00 – 12:00 PM (PT) 2:00 – 3:00 PM (ET) |
Long Break |
|
12:00 – 1:30 PM (PT) 3:00 – 4:30 PM (ET) |
Case Reports Awards |
|
1:30 – 2:20 PM (PT) 4:30 – 5:20 PM (ET) |
OM-COVID Session | Can Dentists Play a Role in Ending the Pandemic? | |
2:20 – 2:30 PM (PT) 5:20 – 5:30 PM (ET) |
Break | |
2:30 – 3:30 PM (PT) 5:30 – 6:30 PM (ET) |
Installation and Awards, and Closing Remarks |
American Academy of Oral Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Live
Attendance American Academy of Oral Medicine designates this activity for 17 continuing education credits.
Self-Study
American Academy of Oral Medicine designates this activity for 14 continuing education credits.